Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQS0P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $45,284
Award facts
- Contract value 100% obligated
- $45,284.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $45,284.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of RINVOQ ER 15 mg tablets (30-unit packages). This is a non-set-aside, competitively awarded contract with performance completion targeted for December 15, 2025, and fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's track record with DLA demonstrates capability to fulfill diverse federal medical supply requirements through open competition, with delivery orders typically structured as firm fixed-price contracts. This award for RINVOQ ER tablets—a prescription immunosuppressant medication—reflects AmerisourceBergen's role in supplying specialized pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FQS0P?
SPE2DR26FQS0P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FQS0P worth?
The government has obligated $45,284 on SPE2DR26FQS0P.
Is contract SPE2DR26FQS0P an order under another contract?
Yes. SPE2DR26FQS0P is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS0P competed?
The extent of competition for SPE2DR26FQS0P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award